Jaguar Health (JAGX) Free Cash Flow Growth (5y) (2019 - 2026)
Jaguar Health (JAGX) Free Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.17% |
| Dec 31, 2025 | -0.97% |
| Sep 30, 2025 | -10.68% |
| Jun 30, 2025 | -9.13% |
| Mar 31, 2025 | -11.19% |
| Dec 31, 2024 | -19.06% |
| Sep 30, 2024 | 4.88% |
| Jun 30, 2024 | -10.81% |
| Mar 31, 2024 | -12.92% |
| Dec 31, 2023 | -10.03% |
| Sep 30, 2023 | -17.04% |
| Jun 30, 2023 | -10.90% |
| Mar 31, 2023 | -0.69% |
| Dec 31, 2022 | 0.86% |
| Sep 30, 2022 | -23.61% |
| Jun 30, 2022 | -58.11% |
| Mar 31, 2022 | -92.84% |
| Dec 31, 2021 | -26.87% |
| Sep 30, 2021 | -22.71% |
| Jun 30, 2021 | -21.16% |